Sverre E Kjeldsen

发表

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.

Sverker Jern, Richard B Devereux, Lars H Lindholm, 2006, JAMA.

Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting.

Giuseppe Mancia, Gianfranco Parati, Athanase Benetos, 2006, Journal of hypertension.

Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

S. Kjeldsen, S. Julius, Sverre E Kjeldsen, 2004, American heart journal.

Plasma catecholamines, blood pressure responses and perceived stress during mental arithmetic stress in young men

S. Kjeldsen, H. Reims, A. Høieggen, 2004, Blood pressure.

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks

Giuseppe Mancia, Gianfranco Parati, Knut Liestøl, 2018, European heart journal.

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Piotr Ponikowski, Jose Luis Zamorano, Giuseppe Mancia, 2007, European heart journal.

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Michael Böhm, Giuseppe Mancia, Stéphane Laurent, 2007, Journal of hypertension.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Thomas Kahan, Giuseppe Mancia, Krzysztof Narkiewicz, 2018, European heart journal.

[ESH/ESC 2007 Guidelines for the management of arterial hypertension].

Piotr Ponikowski, Giuseppe Mancia, Margus Viigimaa, 2007, Revista espanola de cardiologia.

[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

Thomas Kahan, Giuseppe Mancia, Krzysztof Narkiewicz, 2018, Giornale italiano di cardiologia.

The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials

S. Kjeldsen, Sverre E Kjeldsen, A. Westheim, 2006, Expert opinion on pharmacotherapy.

Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study

Lauri Toivonen, Lasse Oikarinen, Matti Viitasalo, 2005, Circulation.

All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy.

Richard B Devereux, P. Okin, R. Devereux, 2010, European heart journal.

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension

Michael Böhm, Giuseppe Mancia, Diederick E Grobbee, 2014, Blood pressure.

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Steven Snapinn, Ulf de Faire, Richard B Devereux, 2002, The Lancet.

Hypertension and cardiovascular risk: General aspects

S. Kjeldsen, Sverre E Kjeldsen, 2017, Pharmacological research.

Relationship of Sudden Cardiac Death to New-Onset Atrial Fibrillation in Hypertensive Patients With Left Ventricular Hypertrophy

Richard B Devereux, P. Okin, R. Devereux, 2013, Circulation. Arrhythmia and electrophysiology.

[2018 ESC/ESH Guidelines for the management of arterial hypertension].

Thomas Kahan, Giuseppe Mancia, Krzysztof Narkiewicz, 2019, Kardiologia polska.